Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction. (Q46429199)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Joy Melnikow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Debora Paterniti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Rahman Azari

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Christina Kuenneth

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Miriam Kuppermann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

James Nuovo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Janet Keyzer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Stuart Henderson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

English

0 references

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

1996-2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15825209%20AND%20SRC:MED&resulttype=core&format=json

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

Chemoprevention of breast cancer: recommendations and rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

Qualitative research and evidence based medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

7 January 2021

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

7 January 2021

Overview of the main outcomes in breast-cancer prevention trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

7 January 2021

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

7 January 2021

How do women of diverse backgrounds value prenatal testing outcomes?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

7 January 2021

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

7 January 2021

Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

7 January 2021

Women's interest in chemoprevention for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

7 January 2021

Patient reluctance toward tamoxifen use for breast cancer primary prevention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

7 January 2021

Making good decisions about breast cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

7 January 2021

Re: tamoxifen prevention of breast cancer: an instance of the fingerpost

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

7 January 2021

First do no harm: extending the debate on the provision of preventive tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20981

7 January 2021